**Core Concept**
The question is testing the methods of **surfactant administration** in patients, particularly in neonates with respiratory distress syndrome. Surfactant replacement therapy is crucial for reducing surface tension in the lungs and improving gas exchange.

**Why the Correct Answer is Right**
Since the correct answer is not provided, let's discuss the common methods of surfactant administration: intratracheal instillation, where surfactant is directly administered into the trachea, and aerosolized administration.

**Why Each Wrong Option is Incorrect**
**Option A:** This option might be incorrect if it suggests an oral route, which is not a standard method for surfactant administration.
**Option B:** If this option mentions intravenous administration, it would be incorrect because surfactant is not given intravenously due to its large molecular size and potential for systemic side effects.
**Option C:** This could be incorrect if it proposes a subcutaneous route, which is not used for surfactant administration.
**Option D:** Without the specific details of option D, it's challenging to provide a precise reason for its incorrectness.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that surfactant administration is most effective when given early in the course of respiratory distress syndrome, and its administration should be guided by protocols that consider the patient's weight, gestational age, and clinical condition.

**Correct Answer:** Not provided in the query.